⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Cigna removed its COVID-19 pandemic risk disclosure, reflecting the transition from acute pandemic uncertainty to endemic business operations. The company added a new risk factor addressing artificial intelligence and machine learning regulatory challenges, signaling heightened focus on emerging technology compliance issues. Two substantive modifications to existing risk factors - government regulation and litigation/regulatory risks - suggest Cigna expanded or refined its disclosure around evolving regulatory and legal exposures.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟢 New in Current Filing Our use of artificial intelligence and machine learning present regulatory and legal challenges that could negatively affect our business and our reputation. 🔒

🔴 No Match in Current Filing The scale, scope and duration of the ongoing COVID-19 pandemic continues to be unknown and the overall impact on our business, operating results, cash flows or financial condition has been and may continue to be material. 🔒

🟡 Modified Our business is subject to substantial government regulation, as well as new laws or regulations or changes in existing laws or regulations that could have a material adverse effect on our business, results of operations, financial condition and liquidity. 🔒

🟡 Modified We face risks related to litigation, regulatory audits and investigations. 🔒

4 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →